Researcher Spotlight: Melissa Little, Ph.D.

Researcher Spotlight: Melissa Little, Ph.D.

Published on November 16, 2021 | The PKD Foundation’s principal mission is to support basic, translational, and clinical research that will benefit patients with autosomal dominant and autosomal recessive polycystic kidney disease (ADPKD and ARPKD). This mission is...
Researcher Spotlight: Feng Qian, Ph.D.

Researcher Spotlight: Feng Qian, Ph.D.

Published on November 2, 2021 Feng Qian, Ph.D., University of Maryland School of Medicine   How did you first get involved in PKD research? Feng: I first got involved in PKD research at my postdoctoral fellowship at Yale and then Johns Hopkins University. The...
Researcher Spotlight: Eduardo Chini, M.D., Ph.D.

Researcher Spotlight: Eduardo Chini, M.D., Ph.D.

Published on July 27, 2021 Eduardo Chini, M.D., Ph.D., Mayo Clinic   How did you first get involved in PKD research? Eduardo: I’ve trained with Dr. Thomas Dousa one of the found fathers of biochemical nephrology. He studied signal transduction in kidney disease...
When a Clinical Trial Fails

When a Clinical Trial Fails

Published on June 29, 2021 | On June 1, the STAGED-PKD study was halted due to an inability to meet futility criteria. The study was looking at an investigational drug called venglustat to treat ADPKD. Over 500 patients signed up to participate. What does it mean to...
Researcher Spotlight: Xiangqin Cui, Ph.D.

Researcher Spotlight: Xiangqin Cui, Ph.D.

Published on June 22, 2021 Xiangqin Cui, Ph.D., Emory University   How did you first get involved in PKD research? Xiangqin: When I was a postdoc in Dr. Gary Churchill’s lab at the Jackson Laboratory, Dr. Churchill had collaborations with Dr. Lisa Guay-Woodford...